CELC - Latest News
Celcuity Inc. (CELC), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $3.08B. Beta to the broader market is 0.16.
The article list below shows the most recent CELC headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CELC Headlines
Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
globenewswire.com - Oct 5, 2026
Rapid oral presentation of additional sub-group analyses from the VIKTORIA-1 PIK3CA mutant-type cohort Poster presentation of a comparative analysis o
Celcuity Appoints David Gryska To Its Board Of Directors
globenewswire.com - Oct 2, 2026
Mr. Gryska brings decades of strategic and financial leadership experience to Celcuity's Board Mr.
Celcuity (NASDAQ:CELC) Shares Gap Up – Time to Buy?
defenseworld.net - Oct 2, 2026
Celcuity, Inc. (NASDAQ: CELC - Get Free Report)'s share price gapped up prior to trading on Wednesday.
Why Celcuity Stock Was a Winner on Wednesday
fool.com - Sep 30, 2026
This is a breast cancer treatment, Revtorpyk. It was approved by the FDA in July.
Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States
globenewswire.com - Sep 30, 2026
REVTORPYK is indicated for patients with HR+/HER2- advanced breast cancer without a PIK3CA mutation detected following progression on or after at leas
How News Affects CELC Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CELC's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CELC news questions
- What is the latest CELC news headline?
- The most recent CELC headline (Oct 5, 2026) is "Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CELC news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CELC news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CELC options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.